Previous research has shown that inhibition of Cadherin 11 (CDH11)—the expression of which is correlated with shorter survival in TNBC—can downregulate β-catenin, which suppresses the canonical Wnt signaling pathway, thereby inhibiting the cancer stem-like phenotype in TNBC [49,50,51]. The gene discussed is CDH11; the disease is cancer.